ロード中...
Programmed Death 1 Ligand Expression in the Monocytes of Patients with Hepatocellular Carcinoma Depends on Tumor Progression
Monocytes (CD14(+) cells) from advanced-stage hepatocellular carcinoma (HCC) patients express programmed death 1 ligand (PD-L)/PD-1 and suppress the host antitumor immune response. However, it is unclear whether cancer progression is associated with CD14(+) cells. We compared CD14(+) cell properties...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7465257/ https://ncbi.nlm.nih.gov/pubmed/32824016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12082286 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|